Remove Chemotherapy Remove Communication Remove Immunization
article thumbnail

Hospital Universitario and Josep Carreras develop cell therapy for leukaemia

Pharmaceutical Technology

It could be used for T-Cell Acute Lymphoblastic Leukaemia (T-ALL) treatment in patients for whom bone marrow transplantation and chemotherapy failed to work. CAR-T therapies are based on the patient’s immune cell modification and can express artificial chimeric receptors that can identify and remove tumour cells.

Hospitals 110
article thumbnail

FDA pulls approval of COVID-19 antibody treatment due to inefficacy against variants

Pharmafile

The antibody treatment was previously used as an additional layer of protection against the virus for those with compromised immune systems, such as those undergoing chemotherapy, or organ-transplant patients. read more

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

In the precision medicine era, the line between products and services is blurred

pharmaphorum

Traditionally, cancer patients are treated using “one size fits all” interventions like chemotherapy, radiotherapy and surgery. Visual communication. These tools not only make it easier to understand the service, but they can also help simplify communication and increase alignment between the many individuals engaged in the project.

article thumbnail

SNIPR targets antibiotic resistance with CRISPR-based gene therapy trial

Pharmaceutical Technology

Chemotherapy used to treat blood cancer results in increased intestinal permeability, making E. Subjects were dosed over seven days, and reportedly only experienced mild to moderate side effects with no withdrawals. coli a frequent cause of bloodstream infections that carries a 15-20% fatality rate.

article thumbnail

Lymphoma Action – championing the patient voice in cell therapy

pharmaphorum

1 Every year, 19,500 people are diagnosed with lymphoma 2 – a cancer affecting a certain type of white blood cell within the immune system – and can be classed as either slow or fast growing. Now, people living with particular types of lymphoma have individualised options beyond chemotherapy for the first time.”.

article thumbnail

Xenetic Biosciences forms research collaboration with TSRI

Pharmaceutical Technology

The company is focused on its planned first-in-human trial designed for assessing DNase, along with immune checkpoint inhibitors or chemotherapy. The collaboration will also support the development of XCART, a DNase-armoured personalised chimeric antigen receptor (CAR) T cell technology for the treatment of B-Cell lymphomas.

article thumbnail

Solutions for Constipation Relief

The Thyroid Pharmacist

Chemotherapy agents: Chemotherapy agents can lead to constipation in a variety of ways such as slowing the movements of the intestinal tract or creating inflammation that disrupts digestive function. Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation.